The Nocebo Response


You are currently browsing comments. If you would like to return to the full story, you can read the full entry here: “The Nocebo Response”.

No related posts.

Tags: , , , , ,

  1. Bruce’s avatar

    I read about the nocebo effect recently in a scientific paper reviewing all the popular low-carb diet books. Two examples were given of studies comparing low-fat to low-carb diets. All subjects met with a dietitian several times, who probably reinforced the low-fat diet (placebo effect) and discouraged the low carb dieters (nocebo effect). This variable needs to be controlled. All subjects should be given reinforcement or none of them should.

    http://www.scientificexploration.org/jse/articles/pdf/18.1_kauffman.pdf

  2. admin’s avatar

    Thanks for your comment, Bruce. I couldn’t agree more that trials need better controls for both the placebo and nocebo effect.

    Some have argued (rightly, I believe) that an inert placebo control isn’t enough, however, to guarantee a double-blind trial. Patients taking the active drug in a study often experience side effects, which of course leads them to suspect they are taking the drug and not the placebo and ruins the blind.

    A more accurate alternative would be an “active placebo”, which is a substance that does not address the disease in question but has some relatively benign physiological effects like producing dry mouth or stimulation (like a caffeine pill, perhaps). In studies done with active placebos, the difference between the efficacy of antidepressants and placebo was virtually nil.

Bad Behavior has blocked 359 access attempts in the last 7 days.

Better Tag Cloud